Literature DB >> 1127578

Application of the Loo-Riegelman absorption method.

J G Wagner.   

Abstract

The Loo-Reigelman absorption method provides the correct A infinity/V1 value and the correct rate constant ka (if absorption is first order), whether metabolism occurs in compartment 1 only, compartment 2 only, or both compartments 1 and 2 of the two-compartment open models. In cases where there is metabolism in compartment 2, the disposition parameters estimated from intravenous data are only apparent and not the real values. The correct A infinity/V1 and ka values are obtained, however, only under conditions not hithertofore specified. Thes conditions are that there must be essentially no bias in the disposition parameters k12, k21 and kel, and in the C0 value estimated from the intravenous data, and that in the oral study a large number of interpolated plasma concentrations, as well as the observed plasma concentrations, must be used, especially for drugs with long half-lives. It is shown that application of the Guggenheim method to the initial At/V1, t values frequently provides a better method of estimating A infinity/V1 and ka than the classical method. If biased disposition parameters are used in application of the Loo-Reigelman method oral data, then essentially the correct ovalue of ka will be estimated, but the estimate of A infinity/V1 will be approximately equal to the true value of A infinity/V1 multiplied by the ratio of the biased C0 value (obtained in fitting the intravenous data) to the true C0 value of the intravenous data. The above indicates that intravenous data should be fitted by computer until there are no systematic deviations or trends and as small a sum of squared deviations as possible is obtainedmthe oral data should be fitted by spline or Akima methods, or similar procedures, to produce a function which passes through each observed plasma concentration and at the same time provides a large number of interpolated concentration data.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127578     DOI: 10.1007/bf01066595

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  7 in total

1.  Kinetics of warfarin absorption in man.

Authors:  A Breckenridge; M Orme
Journal:  Clin Pharmacol Ther       Date:  1973 Nov-Dec       Impact factor: 6.875

2.  Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression.

Authors:  J Fried; S Zietz
Journal:  Phys Med Biol       Date:  1973-07       Impact factor: 3.609

3.  Pharmacokinetic analysis of blood level data interpreted by a two-compartment model.

Authors:  T Suzuki; Y Saito
Journal:  Chem Pharm Bull (Tokyo)       Date:  1973-07       Impact factor: 1.645

4.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

5.  Pharmacokinetic profile of coumermycin A.

Authors:  S A Kaplan
Journal:  J Pharm Sci       Date:  1970-03       Impact factor: 3.534

6.  Estimation of rate constants for absorption and elimination from blood concentration data.

Authors:  J G Wagner; C M Metzler
Journal:  J Pharm Sci       Date:  1967-05       Impact factor: 3.534

7.  Use of computers in pharmacokinetics.

Authors:  J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1967 Jan-Feb       Impact factor: 6.875

  7 in total
  9 in total

1.  Do you need a pharmacokinetic model, and, if so, which one?

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.

Authors:  K Okimoto; A Ohike; R Ibuki; O Aoki; N Ohnishi; T Irie; K Uekama; R A Rajewski; V J Stella
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 3.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

4.  An area function method for estimating the apparent absorption rate constant.

Authors:  H Cheng; A E Staubus; L Shum
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

5.  Linear pharmacokinetic models: geometric construction to determine transfer and elimination rate constants.

Authors:  N P Chau
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

6.  Mathematical basis and generalization of the Loo-Riegelman method for the determination of in vivo drug absorption.

Authors:  D P Vaughan; M Dennis
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

7.  In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.

Authors:  Jie Shen; Stephanie Choi; Wen Qu; Yan Wang; Diane J Burgess
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

8.  Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system.

Authors:  R H Reuning; S H Liao; A E Staubus; S B Ashcraft; D A Downs; S E Harrigan; J N Wiley; D L Wise
Journal:  J Pharmacokinet Biopharm       Date:  1983-08

9.  Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.

Authors:  K Okimoto; M Miyake; N Ohnishi; R A Rajewski; V J Stella; T Irie; K Uekama
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.